Theriva biologics to participate in upcoming investor conferences

Rockville, md., dec. 01, 2022 (globe newswire) -- theriva biologics (nyse american: tovx), (“theriva” or the “company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that company's management will participate in the following upcoming investor conferences in december.
TOVX Ratings Summary
TOVX Quant Ranking